Literature DB >> 17931108

Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults.

Wendi Zhou1, Madeva Sharma, Joy Martinez, Tumul Srivastava, Don J Diamond, Wendy Knowles, Simon F Lacey.   

Abstract

BK polyomavirus (BKV) reactivation is associated with a failure of T cell immunity in kidney transplant patients, and may lead to BKV-associated nephropathy (BKVN) and loss of the allograft. BKV reactivation in hematopoietic stem cell transplant recipients is associated with hemorrhagic cystitis. We have investigated T cell responses to overlapping peptide mixtures corresponding to the whole BKV major T antigen (TAg) and major capsid protein (VP1) in peripheral blood mononuclear cell samples from a cohort of healthy BKV-seropositive subjects. The majority of these individuals possessed populations of both CD8(+) and CD4(+) T cells specific for these BKV antigens. After expansion in culture, the majority of the BKV-specific CD4(+) T cells, in addition to expressing CD40L (CD154), secreted both interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha, contained both granzyme A and granzyme B, and degranulated/mobilized CD107 in response to antigen-specific stimulation. These T cells thus represent potentially functional BKV-specific cytotoxic CD4(+) T lymphocytes. Secretion of both TNF-alpha and IFN-gamma by CD154(+)CD4(+) T cells on BKV-specific stimulation was associated with higher levels of granzyme B and a higher proportion of degranulating cells compared with CD154(+)CD4(+) T cells producing only IFN-gamma or neither cytokine. These healthy subjects also harbored populations of functional CD8(+) T cells specific for one or more of three newly defined HLA-A 02-restricted cytotoxic T lymphocyte epitopes within the BKV TAg as well as two HLA-A 02-restricted epitopes within the BKV VP1 we have previously described. The BKV-specific CD4(+) T cells characterized in this study may play a part in maintaining persistent memory T cell responses to the virus and thus contribute to the immune control of BKV in healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931108     DOI: 10.1089/vim.2007.0030

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  31 in total

1.  A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

Authors:  Benjamin J D Weist; Patrizia Wehler; Linda El Ahmad; Michael Schmueck-Henneresse; Jason M Millward; Mikalai Nienen; Avidan U Neumann; Petra Reinke; Nina Babel
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

Review 2.  Polyomavirus-associated nephropathy.

Authors:  Cristina Costa; Rossana Cavallo
Journal:  World J Transplant       Date:  2012-12-24

3.  Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.

Authors:  Nissreen Elfadawy; Stuart M Flechner; Jesse D Schold; Titte R Srinivas; Emilio Poggio; Richard Fatica; Robin Avery; Sherif B Mossad
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

4.  Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection.

Authors:  Eugene Lin; Christopher C Kemball; Annette Hadley; Jarad J Wilson; Amelia R Hofstetter; Christopher D Pack; Aron E Lukacher
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 5.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

6.  Stimulation of BK virus DNA replication by NFI family transcription factors.

Authors:  Bo Liang; Irina Tikhanovich; Heinz Peter Nasheuer; William R Folk
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

7.  Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.

Authors:  Hanna Kim; Kristina M Brooks; Cheng Cai Tang; Paul Wakim; Mary Blake; Stephen R Brooks; Gina A Montealegre Sanchez; Adriana A de Jesus; Yan Huang; Wanxia Li Tsai; Massimo Gadina; Apurva Prakash; Jonathan Marcus Janes; Xin Zhang; William L Macias; Parag Kumar; Raphaela Goldbach-Mansky
Journal:  Clin Pharmacol Ther       Date:  2017-12-08       Impact factor: 6.875

8.  The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Authors:  Mireille Laforge; Ricardo Silvestre; Vasco Rodrigues; Julie Garibal; Laure Campillo-Gimenez; Shahul Mouhamad; Valérie Monceaux; Marie-Christine Cumont; Henintsoa Rabezanahary; Alain Pruvost; Anabela Cordeiro-da-Silva; Bruno Hurtrel; Guido Silvestri; Anna Senik; Jérôme Estaquier
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

9.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  The role of CD4(+) T cells in BKV-specific T cell immunity.

Authors:  B J D Weist; M Schmueck; H Fuehrer; A Sattler; P Reinke; N Babel
Journal:  Med Microbiol Immunol       Date:  2014-07-23       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.